Discussion of what idiopathic pulmonary fibrosis (IPF) is, how IPF is diagnosed and treated, and what state of the art treatments lie ahead for IPF.
Discussion of what causes pulmonary fibrosis in people who do not have IPF, and how these forms of pulmonary fibrosis are diagnosed and treated.
Discussion of what lung transplant results are like for individuals living with pulmonary fibrosis, and what are some of the factors doctors and patients consider when deciding whether lung transplantation is right for them.
Discussion of what clinical trials and research programs UVA conducts in interstitial lung disease, and UVA's role on the international stage as a Center of Excellence in pulmonary fibrosis and multicenter collaborator in research to find new treatments for ILD.
Discussion of the impact of COVID19 virus on the pulmonary fibrosis community, and the considerations and precautions that must be made while living with pulmonary fibrosis during a pandemic.
Discussion of resources to maintain a positive and resilient outlook and robust physical activity while living with pulmonary fibrosis.
Dr. Ganesh Raghu, a world renowned medical expert and leader for over 30 years in pulmonary fibrosis, discusses the past, present and future of pulmonary fibrosis patient care.
Questions and Answers from the Live 2020 Pulmonary Fibrosis Conference broadcast.
